Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-19

Clinical Trial Update: Study in Participants With Acute Migraines Headaches [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in participants with acute migraine headaches was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eli Lilly and Company

Snippet

Sponsor: Eli Lilly and Company | Conditions: Migraine Headache | Phase 2 | Status: TERMINATED | Results posted: 2020-05-19